You are here: Industry Insights > drug sales

News List

Diabetes drug sales ease Boehringer's patent-loss pain fiercepharma
April 21, 2019
As sales of its blockbuster asthma and COPD drug Spiriva flagged in 2018, Boehringer Ingelheim needed a boost from its other products. Turns out diabetes was the key.
Johnson & Johnson's fourth-quarter drug sales rise 5.3 percent, led by Stelara, Imbruvica, Darzalex firstwordpharma
January 22, 2019
Credit Suisse analyst Vamil Divan noted that Johnson & Johnson's quarterly profit was boosted by from an effective tax rate of 2.6 percent, amounting to just $80 million. Meanwhile, J.P. Morgan analyst Chris Schott said the positive outlook for the compan
Philadelphia looks to register pharma reps, ban gifts fiercepharma
December 05, 2018
It may soon be tougher to be a pharma sales rep in Philadelphia. Its city council will hold a public hearing Friday on a proposed bill (PDF) to regulate pharma manufacturer reps...
Eisai partners with Chong Kun Dang for drug sales biospectrumasia
June 06, 2018
Chong Kun Dang will focus on sales and marketing for clinics, and Eisai Korea, for general hospitals.
Top 50 Drugs by Global Sales in 2017: Humira Topped for 6 Times Dopine
March 06, 2018
Humira continued to be strong, with sales of 2017 fiscal year growing by USD 2.69 billion to reach USD 18.427 billion in total, becoming a “6-time champion”.
After a slow start, Novartis finally gains market traction with heart drug Entresto fiercepharma
August 16, 2017
Novartis CEO Joe Jimenez told investors during a recent earnings call that heart failure drug Entresto is winning over insurers.